Managed Care Best Practices In the Treatment and Management of Psoriasis

The emergence of biologic response modifiers for the treatment of plaque psoriasis herals a promising era for a patient population that has long been underserved. Patients and physicians have high expectations now that therapies that are curative, not just palliativem are coming to market. MCOs will take notice, too, as the pharmacotherapeutic focus moves from the older products to the new and costlier biologic therapies. This supplement explores the issues inherent in in this transition.


  • Overview of Psoriasis: Current and Emerging Treatment Options
  • The Cost of Psoriasis
  • Managed Care’s Perspective on Treatment of Plaque Psoriasis
  • Roundtable Discussion: Improving the Standard of Care for Patients With Psoriasis